Your browser doesn't support javascript.
Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens.
Del Valle, Rut; Ballesteros, Álvaro; Calvo, Cristina; Sainz, Talía; Mendez, Ana; Grasa, Carlos; Molina, Paula R; Mellado, María J; Sanz-Santaeufemia, Francisco J; Herrero, Blanca; Calleja, Lourdes; Soriano-Arandes, Antoni; Melendo, Susana; Rincón-López, Elena; Hernánz, Alicia; Epalza, Cristina; García-Baeza, Carmen; Rupérez-García, E; Berzosa, Arantxa; Ocaña, Angustias; Villarroya-Villalba, Alvaro; Barrios, Ana; Otheo, Enrique; Galán, Juan C; Rodríguez, Mario José; Mesa, Juan M; Domínguez-Rodríguez, Sara; Moraleda, Cinta; Tagarro, Alfredo.
  • Del Valle R; Pediatrics Department, Pediatrics Research Group, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain.
  • Ballesteros Á; Pediatric Research and Clinical Trials Unit (UPIC), Pediatrics Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Fundación de Investigación Biomédica Hospital 12 de Octubre, RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Calvo C; Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Sainz T; Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Mendez A; Research Center, Centro de Investigación en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain, Madrid, Spain.
  • Grasa C; Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Molina PR; Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Mellado MJ; Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Sanz-Santaeufemia FJ; Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Herrero B; Pediatrics Department, Hospital Universitario Niño Jesús, Madrid, Spain.
  • Calleja L; Pediatrics Department, Hospital Universitario Niño Jesús, Madrid, Spain.
  • Soriano-Arandes A; Pediatrics Department, Hospital Universitario Niño Jesús, Madrid, Spain.
  • Melendo S; Infectious Diseases and Pediatric Immunology Unit, Department of Pediatrics, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Rincón-López E; Infectious Diseases and Pediatric Immunology Unit, Department of Pediatrics, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Hernánz A; Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Epalza C; Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • García-Baeza C; Research Center, Gregorio Marañón Research Institute (IiSGM), Madrid, Spain.
  • Rupérez-García E; Pediatric Research and Clinical Trials Unit (UPIC), Pediatrics Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Fundación de Investigación Biomédica Hospital 12 de Octubre, RITIP (Translational Research Network in Paediatric Infectious Diseases), Madrid, Spain.
  • Berzosa A; Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Ocaña A; Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Villarroya-Villalba A; Pediatrics Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Barrios A; Pediatrics Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Otheo E; Pediatric Intensive Care Unit Department, Hospital La Moraleja, Madrid, Spain.
  • Galán JC; Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Rodríguez MJ; Pediatrics Department, Pediatrics Research Group, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain.
  • Mesa JM; Pediatrics Department, Hospital Universitario Ramón y Cajal, Universidad de Alcalá Madrid, Madrid, Spain.
  • Domínguez-Rodríguez S; Microbiology Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Moraleda C; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Tagarro A; Microbiology Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS), Madrid, Spain.
Pediatr Pulmonol ; 57(10): 2374-2382, 2022 10.
Article in English | MEDLINE | ID: covidwho-1905935
ABSTRACT

BACKGROUND:

Pneumonia is a frequent manifestation of coronavirus disease 2019 (COVID-19) in hospitalized children.

METHODS:

The study involved 80 hospitals in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spanish Pediatric National Cohort. Participants were children <18 years, hospitalized with SARS-CoV-2 community-acquired pneumonia (CAP). We compared the clinical and radiological characteristics of SARS-CoV-2-associated CAP with CAP due to other viral etiologies from ValsDance (retrospective) cohort.

RESULTS:

In total, 151 children with SARS-CoV-2-associated CAP and 138 with other viral CAP were included. Main clinical features of SARS-CoV-2-associated CAP were cough, fever, or dyspnea. Lymphopenia was found in 43% patients and 15% required admission to the pediatric intensive care unit (PICU). Chest X-ray revealed condensation (42%) and other infiltrates (58%). Compared with CAP from other viral pathogens, COVID-19 patients were older, with lower C-reactive protein (CRP) levels, less wheezing, and greater need of mechanical ventilation (MV). There were no differences in the use of continuous positive airway pressure (CPAP) or HVF, or PICU admission between groups.

CONCLUSION:

SARS-CoV-2-associated CAP in children presents differently to other virus-associated CAP children are older and rarely have wheezing or high CRP levels; they need less oxygen but more CPAP or MV. However, several features overlap and differentiating the etiology may be difficult. The overall prognosis is good.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Community-Acquired Infections / COVID-19 Type of study: Cohort study / Etiology study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans Language: English Journal: Pediatr Pulmonol Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ppul.26042

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Community-Acquired Infections / COVID-19 Type of study: Cohort study / Etiology study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans Language: English Journal: Pediatr Pulmonol Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ppul.26042